Pubblicazioni

Interferon lambda 4 rs368234815 TT>Î´G variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

2017 - HEPATOLOGY

Petta, S; Valenti, Laura; Tuttolomondo, A; Dongiovanni, P; Pipitone, Rm; CammÃ , C; Cabibi, D; Di Marco, V; Fracanzani, Al; Badiali, S; Nobili, V; Fargion, S; Grimaudo, S; CraxÃ¬, A.

Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients

2017 - PHARMACOGENOMICS

Sini, V.; Botticelli, A.; Lunardi, G.; Gori, S.; Marchetti, P.

Pubblicazioni

Interferon lambda 4 rs368234815 TT&gt;Î´G variant is associated with liver damage in patients with nonalcoholic fatty liver disease.

Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients

Interferon lambda 4 rs368234815 TT>Î´G variant is associated with liver damage in patients with nonalcoholic fatty liver disease.